D
Dominique Larrey
Researcher at University of Montpellier
Publications - 16
Citations - 1524
Dominique Larrey is an academic researcher from University of Montpellier. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 12, co-authored 16 publications receiving 1326 citations. Previous affiliations of Dominique Larrey include French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.
Christophe Corpechot,Olivier Chazouillères,Alexandra Rousseau,Antonia Le Gruyer,François Habersetzer,Philippe Mathurin,Odile Goria,Pascal Potier,Anne Minello,Christine Silvain,Armand Abergel,Maryline Debette-Gratien,Dominique Larrey,Olivier Roux,Jean-Pierre Bronowicki,Jérôme Boursier,Victor de Ledinghen,Alexandra Heurgué-Berlot,Eric Nguyen-Khac,Fabien Zoulim,Isabelle Ollivier-Hourmand,Jean-Pierre Zarski,Gisèle N'Kontchou,Sara Lemoinne,Lydie Humbert,Dominique Rainteau,Guillaume Lefèvre,Luc de Chaisemartin,Sylvie Chollet-Martin,Farid Gaouar,Farid-Hakeem Admane,Tabassome Simon,Raoul Poupon +32 more
TL;DR: Treating patients with primary biliary cholangitis with bezafibrate in addition to ursodeoxycholic acid resulted in a rate of complete biochemical response that was significantly higher than the rate with placebo and ursodespecific acid therapy.
Journal ArticleDOI
The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.
Sonia Molina,Valérie Castet,Valérie Castet,Chantal Fournier-Wirth,Chantal Fournier-Wirth,Lydiane Pichard-Garcia,Lydiane Pichard-Garcia,Rachel Avner,Dror Harats,Joseph Roitelman,Ronald Barbaras,Pierre Graber,Paola Ghersa,Moshe Smolarsky,Ada Funaro,Fabio Malavasi,Dominique Larrey,Dominique Larrey,Joliette Coste,Joliette Coste,Jean-Michel Fabre,Jean-Michel Fabre,Antonio Sa-Cunha,Patrick Maurel,Patrick Maurel +24 more
TL;DR: Low-density lipoprotein receptor is involved at an early stage in infection of normal human hepatocytes by serum-derived HCV virions, irrespective of genotype, viral load or liver donor.
Journal ArticleDOI
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
Eugene R. Schiff,Cjing Lung Lai,Stephanos J. Hadziyannis,Peter Nuehaus,Norah A. Terrault,Massimo Colombo,Hans L. Tillmann,Didler Samuel,Stefan Zuezem,Jean Pierre Villenueve,Sarah Arteburn,Katyna Borroto-Esoda,Carol L. Brosgart,Steven Chuck,Ahmad Obaid Shakil,Jhon Fung,Alfredo Alberti,Anna Lok,Antonio Picciotto,Francesco Torre,Caroline A. Riely,Christian Trepo,Thierry Bizollon,Danielle Bottaa-Fridlund,Rene Gerolami,David D. Douglas,Dinesh Ranjan,D Faust,Joerg Trojan,Edward Gane,Erica Villa,Modentina Boarino,Etienne Sokal,Peter Stärkel,Ferruccio Bonino,Brunetto Maurizio,Fred Gordon,Jo Anne Pratt,Frieder Berr,Ingolf Schiefke,Geoff McCaughan,Simone I. Strasser,Geoffrey Dusheiko,G.-P. Pageaux,Dominique Larrey,Giuseppe Pastore,Teresa Santantonio,Graeme J.M. Alexander,Tracy Woodall,Han Van Vlierberghe,Isabelle Colle,Hugh Harley,Jean Guggenheim,Aline Myx-Staccini,Jean Michel Metreau,Philippe Mavier,John M. Vierling,Tram Tran,Nigel Girgrah,Lisa M. Nyberg,Man-Fung Yuen,Mang Ma,Manuel Delgado Balnco,Manuela Merli,Paola Tanzilli,Mario Angelico,Daniele Di Paolo,Mario Rizzetto,Alfredo Marzano,Pietro Lampertico,Martín Prieto,Marina Berenguer,Martina Felder,Martina Sterneck,Marc Willems,Michael Charlton,Timothy J. Gunneson,Michael Ritter,Michael Voight,Judy Swift,Mitchell L. Shiffman,Nicholas Tassopoulos,Isidoros Klissas,Nikolai Naourmov,Patrick Chamouard,Patrick Marcellin,François Durand,Peter W Angus,Connelly Nathan,Pierluigi Toniutto,Elisabetta Fumo,Pietro Andreone,Carmela Cursaro,Rafael Bárcena,Fernando Garcia Hoz,Reinhard Zachoval,Maria Christina,Robert A. de Man,Herold J. Metselaar +98 more
TL;DR: Adefovir dipivoxil is effective and safe in wait‐listed or post–liver transplantation chronic hepatitis B patients with lamivudine‐resistant HBV and prevents graft reinfection with or without HBIg.
Journal ArticleDOI
Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro
Valerie Castet,Chantal Fournier,Alexandre Soulier,Rozenn Brillet,Joliette Coste,Dominique Larrey,Dominique Larrey,Daniel Dhumeaux,Patrick Maurel,Jean-Michel Pawlotsky +9 more
TL;DR: Primary cultures of healthy, uninfected human hepatocytes are used to show that IFN-α acts primarily through its nonspecific antiviral effects and suggest that primary cultures of human hepatocyte may provide a good model to study intrinsic HCV resistance to IFN.
Journal ArticleDOI
Clinical management of drug-drug interactions in HCV therapy: challenges and solutions.
David M. Burger,David Back,Peter Buggisch,Maria Buti,Antonio Craxì,Graham R. Foster,Hartwig Klinker,Dominique Larrey,Igor G. Nikitin,Stanislas Pol,Massimo Puoti,Manuel Romero-Gómez,Heiner Wedemeyer,Stefan Zeuzem +13 more
TL;DR: An overview of conducted drug-drug interaction studies and a list of contraindicated medications is not enough for the clinical management of these drug- drug interactions.